Stock Details
BHC is Bausch Health Companies Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 6.60$. Average daily volumn in 3 months 8.88M. Market cap 2.57B



Stock symbol : BHC. Exchange : NYSE. Currency : USD
Lastest price : 7.04$. Total volume : 7.49M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Bausch Health Companies Inc. (BHC)
Last Price
7.04$
Change
-0.11
Volume
7.49M

Previous Close7.15
Open6.97
Day Range6.66-7.07
Bid6.79 x 2.2k
Ask7.19 x 1.3k
Volume7.49M
Average Volume8.88M
Market Cap2.57B
Beta1.21
52 Week Range4.00-29.31
Trailing P/E50.29
Foward P/E1.25
Dividend (Yield %)N/A
Ex-Dividend Date2010-11-10



Financial Details


According to Bausch Health Companies Inc.'s financial reports the company's revenue in 2021 were 8.43B an increase(0%) over the years 2020 revenue that were of 8.03B. In 2021 the company's total earnings were -948M while total earnings in 2020 were -560M( +69.29%).


Loading ...



Organization

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical... , and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Market Cap:
2.57B
Revenue:
8.43B
Total Assets:
29.2B
Total Cash:
582M


News about "Bausch Health Companies Inc."

bausch-health-companies-inc-tsebhc-to-post-q3-2022-earnings-of-134-per-share-zacks-research-forecasts-image

Bausch Health Companies Inc. (TSE:BHC) to Post Q3 2022 Earnings of $1.34 Per Share, Zacks Research Forecasts

Source from : Defense World - 3 days ago

Analysts at Zacks Research lifted their Q3 2022 EPS estimates for shares of Bausch Health Companies in a report released on Tuesday, September 20th. Zacks Research analyst E. Bagri now expects that ...See details»


bausch-health-companies-inc-to-post-q4-2022-earnings-of-093-per-share-zacks-research-forecasts-nysebhc-image

Bausch Health Companies Inc. to Post Q4 2022 Earnings of $0.93 Per Share, Zacks Research Forecasts (NYSE:BHC)

Source from : Defense World - 3 days ago

Equities research analysts at Zacks Research boosted their Q4 2022 earnings per share estimates for shares of Bausch Health Companies in a report issued on Tuesday, September 20th. Zacks Research ...See details»


bausch-health-companies-equity-stub-would-benefit-from-ambitious-spinoff-image

Bausch Health Companies: Equity Stub Would Benefit From Ambitious Spinoff

Source from : Seeking Alpha - 4 days ago

Bausch Health is in the process of spinning off its 90% stake in Bausch + Lomb to shareholders. Click to read why the spinoff ultimately seems achievable to me.See details»


BHC Bausch Health Companies Inc.

Source from : Seeking Alpha - 3 days ago

To ensure this doesnโ€™t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...See details»


bausch-health-and-glenmark-announce-the-approval-of-ryaltris-in-canada-image

Bausch Health and Glenmark Announce the approval of RYALTRISยฎ in Canada

Source from : Yahoo - 2 days ago

Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) ("Bausch Health") and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), are pleased to announce that RYALTRISยฎ ...See details»


Bausch Health, Glenmark Specialty Say Health Canada Approves RYALTRIS

Source from : Business Insider - 2 days ago

Bausch Health Companies Inc. (BHC, BHC.TO) and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd., announced ...See details»


Bausch Health Cos. Inc.

Source from : Wall Street Journal - 10 days ago

1 Day BHC -3.40% DJIA -0.45% S&P Mid Cap 400 -1.35% Health Care/Life Sciences 0.34% Richard Charles Mulligan Director Bausch Health Cos., Inc., Biogen, Inc., Kadmon Pharmaceuticals LLC, Biogen ...See details»


why-bausch-health-stock-is-jumping-today-image

Why Bausch Health Stock Is Jumping Today

Source from : Nasdaq - 11 days ago

Bausch Health announced on Aug. 30 that it planned to conduct these exchange offers. At that time, the company stated that holders of nearly 23% of the existing senior notes had agreed to tender all ...See details»


Bausch Health Companies Inc. (BHC) market price of $7.39 offers the impression of an exciting value play

Source from : investchronicle - 5 days ago

Letโ€™s start up with the current stock price of Bausch Health Companies Inc. (BHC), which is $7.39 to be very precise. The Stock rose vividly during the last session to $7.4199 after opening rate of $7 ...See details»


How Raleigh, Triangle lost its most prominent public companies

Source from : The Business Journals - 17 hours ago

Economic development officials have spent millions trying to lure major public companies to put their headquarters in the Triangle, without much to show for it. But the region has lost some big ...See details»


Bausch Health Companies: Top 10 Undervalued Healthcare Stocks on TSE (BHC)

Source from : The Globe and Mail - 5 days ago

Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.See details»


Stocks in play: Bausch Health Companies Inc.

Source from : Yahoo Finance - 2 days ago

(Glenmark) announced that RYALTRISยฎ (olopatadine hydrochloride and mometasone furoate nasal spray) has been approved by Health Canada for the symptomatic treatment of moderate to severe seasonal ...See details»


bausch-health-announces-early-exchange-offer-results-for-exchange-offers-and-consent-solicitations-image

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations

Source from : Newswire - 11 days ago

Bausch Health Companies Inc. (NYSE/TSX: BHC) (the "Company") announced today the results to date of its previously announced offers (the ...See details»


Bausch Health, Glenmark receive Health Canada approval for Ryaltris to treat seasonal allergic rhinitis

Source from : Pharmabiz - 2 days ago

Bausch Health, Glenmark receive Health Canada approval for Ryaltris to treat seasonal allergic rhinitis: Our Bureau, Mumbai Friday, September 23, 2022, 12:45 Hrs [IST] Bausch Heal ...See details»